Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
67 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2023-05-06 | 2023-08-04 | 191883 |
APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2022-03-25 | 2022-05-27 | 157323 |
APO-OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2022-06-12 | 2022-07-23 | 162478 |
APO-OXYCODONE/ACET | 5MG 325MG | TABLET | Resolved | 2020-10-14 | 2020-10-26 | 126303 |
APO-PACLITAXEL INJECTABLE | 6MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19133 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-07-26 | 2017-08-28 | 17296 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-07-31 | 2019-08-19 | 90350 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-08-28 | 2019-12-20 | 92525 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-02-02 | 2023-02-23 | 183492 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-02-09 | 2023-02-23 | 184106 |
APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-03-02 | 2023-04-27 | 185936 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-09-04 | 2019-11-21 | 92989 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-09 | 2022-09-30 | 169060 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-09-06 | 2017-10-03 | 21090 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-01-17 | 2018-02-06 | 36326 |
APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-05-03 | 2024-05-31 | 227034 |
APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-09-20 | 2025-02-21 | 238236 |
APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-10-24 | 2025-02-21 | 241069 |
APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-12-05 | 2025-02-14 | 244896 |
APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-12-03 | 2022-02-14 | 150435 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |